Xue Xia

11PUBLICATIONS
23CO-AUTHORS
Traditional, complementary and integrative medicine not elsewhere classifiedCardiology (incl. cardiovascular diseases)Autonomic nervous systemArts therapyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Sep 03, 2026
Ticagrelor-Aspirin With Thrombolysis by Infarct Patterns in Moderate Ischemic Stroke: TAPIS Subgroup Analysis.

|May 10, 2026
The Evolving Role of High-Sensitivity C-Reactive Protein for Mortality Prediction Across the Spectrum of Cardiovascular-Kidney-Metabolic Syndrome.

|Jan 30, 2026
Association of the Naples Prognostic Score With Functional Outcomes and the Mediating Effects of PhenoAge Acceleration in Patients With Acute Ischemic Stroke or Transient Ischemic Attack: A Nationwide Registry Study.

Zongzheng Lyu, Qin Xu, Yijun Zhang

|Jan 29, 2026
Rationale and design of Ticagrelor with Aspirin Dual Antiplatelet Therapy Combined with Intravenous Thrombolysis in Patients with Ischemic Stroke (TAPIS): a multicentre, randomised, double-blind, parallel group, placebo-controlled trial.

Anxin Wang, Xue Xia, Philip M Bath

|Jan 20, 2026
Cardiovascular outcomes under hypothetical blood-pressure-lowering intervention in type 2 diabetes: A target trial emulation.

Xue Tian, Shouling Wu, Xue Xia

|Dec 18, 2025
Differential Effect of Ticagrelor Versus Clopidogrel by Causative Classification of Stroke Classification and Vascular Cellular Adhesion Molecule-1 Level on the Risk of Recurrent Stroke: A Post Hoc Analysis of the CHANCE-2 Trial.

Hui Li, Xue Xia, Qin Xu

Pageof 2

Frequent Collaborators

10 joint publications

Anxin Wang

5 joint publications

Qin Xu

3 joint publications

Xiaoli Zhang

3 joint publications

Yongjun Wang